Venkatachaliah Girish 4

What Happened

• Venkatachaliah Girish, Chief Technology Officer of agilon health, was the recipient of a grant of 28,000 restricted stock units (RSUs) reported April 1, 2026. In connection with the net settlement of those RSUs, 480 shares were withheld to satisfy income tax withholding obligations; the filing records those 480 shares at $9.75 each for a total of $4,680. The RSUs were reported as acquired at $0.00 per share (typical for awards).

Key Details

• Transaction date: April 1, 2026; Form 4 filed April 3, 2026 (appears timely).
• Grant: 28,000 RSUs (reported at $0.00).
• Withholding: 480 shares withheld to cover taxes — 480 shares × $9.75 = $4,680 (reported as withholding, not a market sale).
• Vesting: RSUs vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment.
• Reverse split: Reported beneficial ownership numbers reflect a 1-for-25 reverse stock split effective March 30, 2026.
• Shares owned after the transaction: filing reports beneficial ownership post‑reverse split (specific total not provided in the summary data). Footnote clarifies withheld shares do not represent a sale.

Context

• This is an award (grant of RSUs) rather than an open‑market purchase or sale; awards are common for executive compensation and do not by themselves indicate near‑term trading intent. The withholding of shares to cover taxes is routine and should not be read as a voluntary sale. The RSUs vest over three years, so future ownership and potential selling activity will depend on vesting and any subsequent filings.